Measurement of heroin and its metabolites by isotope-dilution electron-impact mass spectrometry.
A solid-phase extraction procedure was developed for the isolation of heroin, 6-acetylmorphine, and morphine from blood, plasma, saliva, and urine with subsequent assay by gas chromatography/mass spectrometry. Aprotic solvents, mild elution conditions, and an enzyme inhibitor were used to ensure maximum analyte stability. Samples were extracted and the extract was divided into two equal portions. One portion was assayed directly for heroin; detector response was linear over a concentration range of 1.0 to 250 micrograms/L. The second part of the extract was reacted with N-methyl-bis-trifluoroacetamide and assayed for the trifluoroacetyl derivatives of 6-acetylmorphine and morphine; detector response was linear over a concentration range of 1.0 to 500 micrograms/L. The limit of sensitivity was 1.0 microgram/L for each analyte. Hydrolysis of heroin to 6-acetylmorphine during extraction and analysis was < 5%. The method can be used to corroborate heroin use and to study the pharmacological effects of heroin and its metabolites.
Goldberger
B A
BA
Addiction Research Center, National Institute on Drug Abuse, Baltimore, MD 21224.
Darwin
W D
WD
Grant
T M
TM
Allen
A C
AC
Caplan
Y H
YH
Cone
E J
EJ
D001826:Body Fluids / Q000737:chemistry*; D008401:Gas Chromatography-Mass Spectrometry; D003932:Heroin / Q000032:analysis* / Q000097:blood / Q000652:urine; D006801:Humans; D007201:Indicator Dilution Techniques; D008297:Male; D009020:Morphine / Q000032:analysis* / Q000097:blood / Q000652:urine; D009022:Morphine Derivatives / Q000032:analysis* / Q000097:blood / Q000652:urine; D011786:Quality Control; D012463:Saliva / Q000737:chemistry; D019966:Substance-Related Disorders / Q000378:metabolism
D009022:Morphine Derivatives; D003932:Heroin; D009020:Morphine; C026979:6-O-monoacetylmorphine